Lauren Watson
Post Doctoral Researcher
I am currently developing a stem cell-based model to test the safety and efficacy of oligonucleotide therapies for Myotonic Dystrophy Type 1.
Recent publications
-
Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation.
Journal article
Wong MMK. et al, (2018), Acta Neuropathol Commun, 6
-
A Simplified Method for Generating Purkinje Cells from Human-Induced Pluripotent Stem Cells.
Journal article
Watson LM. et al, (2018), Cerebellum, 17, 419 - 427
-
Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44.
Journal article
Watson LM. et al, (2017), Am J Hum Genet, 101
-
Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44.
Journal article
Watson LM. et al, (2017), Am J Hum Genet, 101
-
Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44.
Journal article
Watson LM. et al, (2017), Am J Hum Genet, 101, 451 - 458